Showing results (11-20 of 1,067) with videos related to
Sort By:
Pageof 107
Therapeutic Advances in Neurological Disorders|December 25, 2010
Evidence-based drug treatment in amyotrophic lateral sclerosis and upcoming clinical trialsAlbert C Ludolph, Sarah JesseTherapeutic Advances in Neurological Disorders|December 25, 2010
Identifying patient subtypes in multiple sclerosis and tailoring immunotherapy: challenges for the futurePhilip L De JagerTherapeutic Advances in Neurological Disorders|December 25, 2010
Progress in the management of paraneoplastic neurological disordersHamid Sadeghian, Steven VerninoTherapeutic Advances in Neurological Disorders|December 25, 2010
Cellular repair strategies in Parkinson's diseaseBeate Winner, Daniela M Vogt-Weisenhorn, Chichung D Lie, et al.Therapeutic Advances in Neurological Disorders|December 25, 2010
New treatment options in status epilepticus: a critical review on intravenous levetiracetamEugen Trinka, Judith DobesbergerTherapeutic Advances in Neurological Disorders|December 25, 2010
Therapeutic options for continuous dopaminergic stimulation in Parkinson's diseaseO K Sujith, Carol LaneTherapeutic Advances in Neurological Disorders|October 22, 2019
Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease courseGreta Zoehner, Andrei Miclea, Anke Salmen, et al.Therapeutic Advances in Neurological Disorders|February 6, 2018
Disease-modifying and symptomatic treatment of amyotrophic lateral sclerosisJohannes Dorst, Albert C Ludolph, Annemarie HuebersTherapeutic Advances in Neurological Disorders|February 6, 2018
Extended-release oral capsule of carbidopa-levodopa in Parkinson diseaseJason Margolesky, Carlos SingerTherapeutic Advances in Neurological Disorders|February 6, 2018
Decreased platelet number in multiple sclerosis during alemtuzumab infusion: a common, transient and clinically silent phenomenonMarco Puthenparampil, Francesca Rinaldi, Lisa Federle, et al.Pageof 107